Published in Bioterrorism Week, January 15th, 2007
Under the terms of the agreement, U.S. Genomics will work with Northrop Grumman Security Systems LLC to complete the development of its technology and secure contracts for its deployment to meet biodetection needs for the U.S. Department of Homeland Security and related biological detection applications.
U.S. Genomics has been awarded phase 1 and 2 contracts by the U.S. Department of Homeland Security Advanced Research Projects Agency (HSARPA) for the development of a...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Bioterrorism Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.